ONCOL RES 润色咨询

ONCOLOGY RESEARCH

出版年份：1992 年文章数：949 投稿命中率： 开通期刊会员，数据随心看

出版周期：Bimonthly 自引率：2.7% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2190202, encodeId=d60a2190202e6, content=这个期刊审稿时间大概多久呀，已经在in review阶段两周了，有没有好兄弟分享一下投稿经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16609175050, createdName=ms1000001807995731, createdTime=Thu Feb 29 21:35:47 CST 2024, time=2024-02-29, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2145244, encodeId=3c4c2145244ac, content=为什么影响因子降这么厉害？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50898365723, createdName=ms6000001780389235, createdTime=Wed Jun 28 17:40:58 CST 2023, time=2023-06-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=884750, encodeId=62df884e5085, content=被中国医院假论文承包，已经玩完, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9e32216429, createdName=pendrin_89355954, createdTime=Sat Sep 12 13:24:17 CST 2020, time=2020-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549342, encodeId=3a055493429d, content=文章接收后就发了一个电子版权说明的epub，也不是proof，该怎么办呢？什么时候交版面费呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=309, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7f662015, createdName=mh880926, createdTime=Mon Nov 20 13:39:00 CST 2017, time=2017-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806865, encodeId=c92e8068653d, content=已经发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72ed2455725, createdName=易小垂, createdTime=Sat Aug 08 00:06:11 CST 2020, time=2020-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096417, encodeId=13f5109641e8c, content=Graphicalabstract是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096418, encodeId=da34109641874, content=投稿中一定要有Graphicalabstract么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806864, encodeId=87ec80686407, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：乳腺癌逆转耐药 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72ed2455725, createdName=易小垂, createdTime=Sat Aug 08 00:05:45 CST 2020, time=2020-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893391, encodeId=a5668933917f, content=版面费多少？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a2285427691, createdName=ms7000000367412444, createdTime=Tue Oct 20 20:47:29 CST 2020, time=2020-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889945, encodeId=ba068899453d, content=已经被多家医院加入黑名单啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eaed2413645, createdName=1237fd56m52暂无昵称, createdTime=Sat Oct 03 20:00:14 CST 2020, time=2020-10-03, status=1, ipAttribution=)]
    2024-02-29 ms1000001807995731 来自重庆

    这个期刊审稿时间大概多久呀，已经在in review阶段两周了，有没有好兄弟分享一下投稿经验

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2190202, encodeId=d60a2190202e6, content=这个期刊审稿时间大概多久呀，已经在in review阶段两周了，有没有好兄弟分享一下投稿经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16609175050, createdName=ms1000001807995731, createdTime=Thu Feb 29 21:35:47 CST 2024, time=2024-02-29, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2145244, encodeId=3c4c2145244ac, content=为什么影响因子降这么厉害？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50898365723, createdName=ms6000001780389235, createdTime=Wed Jun 28 17:40:58 CST 2023, time=2023-06-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=884750, encodeId=62df884e5085, content=被中国医院假论文承包，已经玩完, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9e32216429, createdName=pendrin_89355954, createdTime=Sat Sep 12 13:24:17 CST 2020, time=2020-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549342, encodeId=3a055493429d, content=文章接收后就发了一个电子版权说明的epub，也不是proof，该怎么办呢？什么时候交版面费呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=309, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7f662015, createdName=mh880926, createdTime=Mon Nov 20 13:39:00 CST 2017, time=2017-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806865, encodeId=c92e8068653d, content=已经发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72ed2455725, createdName=易小垂, createdTime=Sat Aug 08 00:06:11 CST 2020, time=2020-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096417, encodeId=13f5109641e8c, content=Graphicalabstract是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096418, encodeId=da34109641874, content=投稿中一定要有Graphicalabstract么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806864, encodeId=87ec80686407, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：乳腺癌逆转耐药 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72ed2455725, createdName=易小垂, createdTime=Sat Aug 08 00:05:45 CST 2020, time=2020-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893391, encodeId=a5668933917f, content=版面费多少？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a2285427691, createdName=ms7000000367412444, createdTime=Tue Oct 20 20:47:29 CST 2020, time=2020-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889945, encodeId=ba068899453d, content=已经被多家医院加入黑名单啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eaed2413645, createdName=1237fd56m52暂无昵称, createdTime=Sat Oct 03 20:00:14 CST 2020, time=2020-10-03, status=1, ipAttribution=)]
    2023-06-28 ms6000001780389235 来自湖北省

    为什么影响因子降这么厉害？

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2190202, encodeId=d60a2190202e6, content=这个期刊审稿时间大概多久呀，已经在in review阶段两周了，有没有好兄弟分享一下投稿经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16609175050, createdName=ms1000001807995731, createdTime=Thu Feb 29 21:35:47 CST 2024, time=2024-02-29, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2145244, encodeId=3c4c2145244ac, content=为什么影响因子降这么厉害？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50898365723, createdName=ms6000001780389235, createdTime=Wed Jun 28 17:40:58 CST 2023, time=2023-06-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=884750, encodeId=62df884e5085, content=被中国医院假论文承包，已经玩完, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9e32216429, createdName=pendrin_89355954, createdTime=Sat Sep 12 13:24:17 CST 2020, time=2020-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549342, encodeId=3a055493429d, content=文章接收后就发了一个电子版权说明的epub，也不是proof，该怎么办呢？什么时候交版面费呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=309, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7f662015, createdName=mh880926, createdTime=Mon Nov 20 13:39:00 CST 2017, time=2017-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806865, encodeId=c92e8068653d, content=已经发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72ed2455725, createdName=易小垂, createdTime=Sat Aug 08 00:06:11 CST 2020, time=2020-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096417, encodeId=13f5109641e8c, content=Graphicalabstract是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096418, encodeId=da34109641874, content=投稿中一定要有Graphicalabstract么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806864, encodeId=87ec80686407, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：乳腺癌逆转耐药 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72ed2455725, createdName=易小垂, createdTime=Sat Aug 08 00:05:45 CST 2020, time=2020-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893391, encodeId=a5668933917f, content=版面费多少？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a2285427691, createdName=ms7000000367412444, createdTime=Tue Oct 20 20:47:29 CST 2020, time=2020-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889945, encodeId=ba068899453d, content=已经被多家医院加入黑名单啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eaed2413645, createdName=1237fd56m52暂无昵称, createdTime=Sat Oct 03 20:00:14 CST 2020, time=2020-10-03, status=1, ipAttribution=)]
    2020-09-12 pendrin_89355954

    被中国医院假论文承包，已经玩完

    3

    展开3条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2190202, encodeId=d60a2190202e6, content=这个期刊审稿时间大概多久呀，已经在in review阶段两周了，有没有好兄弟分享一下投稿经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16609175050, createdName=ms1000001807995731, createdTime=Thu Feb 29 21:35:47 CST 2024, time=2024-02-29, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2145244, encodeId=3c4c2145244ac, content=为什么影响因子降这么厉害？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50898365723, createdName=ms6000001780389235, createdTime=Wed Jun 28 17:40:58 CST 2023, time=2023-06-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=884750, encodeId=62df884e5085, content=被中国医院假论文承包，已经玩完, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9e32216429, createdName=pendrin_89355954, createdTime=Sat Sep 12 13:24:17 CST 2020, time=2020-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549342, encodeId=3a055493429d, content=文章接收后就发了一个电子版权说明的epub，也不是proof，该怎么办呢？什么时候交版面费呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=309, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7f662015, createdName=mh880926, createdTime=Mon Nov 20 13:39:00 CST 2017, time=2017-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806865, encodeId=c92e8068653d, content=已经发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72ed2455725, createdName=易小垂, createdTime=Sat Aug 08 00:06:11 CST 2020, time=2020-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096417, encodeId=13f5109641e8c, content=Graphicalabstract是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096418, encodeId=da34109641874, content=投稿中一定要有Graphicalabstract么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806864, encodeId=87ec80686407, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：乳腺癌逆转耐药 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72ed2455725, createdName=易小垂, createdTime=Sat Aug 08 00:05:45 CST 2020, time=2020-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893391, encodeId=a5668933917f, content=版面费多少？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a2285427691, createdName=ms7000000367412444, createdTime=Tue Oct 20 20:47:29 CST 2020, time=2020-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889945, encodeId=ba068899453d, content=已经被多家医院加入黑名单啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eaed2413645, createdName=1237fd56m52暂无昵称, createdTime=Sat Oct 03 20:00:14 CST 2020, time=2020-10-03, status=1, ipAttribution=)]
    2017-11-20 mh880926

    文章接收后就发了一个电子版权说明的epub，也不是proof，该怎么办呢？什么时候交版面费呢

    2

    展开2条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2190202, encodeId=d60a2190202e6, content=这个期刊审稿时间大概多久呀，已经在in review阶段两周了，有没有好兄弟分享一下投稿经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16609175050, createdName=ms1000001807995731, createdTime=Thu Feb 29 21:35:47 CST 2024, time=2024-02-29, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2145244, encodeId=3c4c2145244ac, content=为什么影响因子降这么厉害？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50898365723, createdName=ms6000001780389235, createdTime=Wed Jun 28 17:40:58 CST 2023, time=2023-06-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=884750, encodeId=62df884e5085, content=被中国医院假论文承包，已经玩完, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9e32216429, createdName=pendrin_89355954, createdTime=Sat Sep 12 13:24:17 CST 2020, time=2020-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549342, encodeId=3a055493429d, content=文章接收后就发了一个电子版权说明的epub，也不是proof，该怎么办呢？什么时候交版面费呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=309, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7f662015, createdName=mh880926, createdTime=Mon Nov 20 13:39:00 CST 2017, time=2017-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806865, encodeId=c92e8068653d, content=已经发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72ed2455725, createdName=易小垂, createdTime=Sat Aug 08 00:06:11 CST 2020, time=2020-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096417, encodeId=13f5109641e8c, content=Graphicalabstract是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096418, encodeId=da34109641874, content=投稿中一定要有Graphicalabstract么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806864, encodeId=87ec80686407, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：乳腺癌逆转耐药 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72ed2455725, createdName=易小垂, createdTime=Sat Aug 08 00:05:45 CST 2020, time=2020-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893391, encodeId=a5668933917f, content=版面费多少？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a2285427691, createdName=ms7000000367412444, createdTime=Tue Oct 20 20:47:29 CST 2020, time=2020-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889945, encodeId=ba068899453d, content=已经被多家医院加入黑名单啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eaed2413645, createdName=1237fd56m52暂无昵称, createdTime=Sat Oct 03 20:00:14 CST 2020, time=2020-10-03, status=1, ipAttribution=)]
    2020-08-08 易小垂

    已经发表

    1

    展开1条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2190202, encodeId=d60a2190202e6, content=这个期刊审稿时间大概多久呀，已经在in review阶段两周了，有没有好兄弟分享一下投稿经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16609175050, createdName=ms1000001807995731, createdTime=Thu Feb 29 21:35:47 CST 2024, time=2024-02-29, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2145244, encodeId=3c4c2145244ac, content=为什么影响因子降这么厉害？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50898365723, createdName=ms6000001780389235, createdTime=Wed Jun 28 17:40:58 CST 2023, time=2023-06-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=884750, encodeId=62df884e5085, content=被中国医院假论文承包，已经玩完, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9e32216429, createdName=pendrin_89355954, createdTime=Sat Sep 12 13:24:17 CST 2020, time=2020-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549342, encodeId=3a055493429d, content=文章接收后就发了一个电子版权说明的epub，也不是proof，该怎么办呢？什么时候交版面费呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=309, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7f662015, createdName=mh880926, createdTime=Mon Nov 20 13:39:00 CST 2017, time=2017-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806865, encodeId=c92e8068653d, content=已经发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72ed2455725, createdName=易小垂, createdTime=Sat Aug 08 00:06:11 CST 2020, time=2020-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096417, encodeId=13f5109641e8c, content=Graphicalabstract是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096418, encodeId=da34109641874, content=投稿中一定要有Graphicalabstract么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806864, encodeId=87ec80686407, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：乳腺癌逆转耐药 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72ed2455725, createdName=易小垂, createdTime=Sat Aug 08 00:05:45 CST 2020, time=2020-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893391, encodeId=a5668933917f, content=版面费多少？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a2285427691, createdName=ms7000000367412444, createdTime=Tue Oct 20 20:47:29 CST 2020, time=2020-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889945, encodeId=ba068899453d, content=已经被多家医院加入黑名单啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eaed2413645, createdName=1237fd56m52暂无昵称, createdTime=Sat Oct 03 20:00:14 CST 2020, time=2020-10-03, status=1, ipAttribution=)]
    2021-12-29 Gym璨烨

    Graphicalabstract是什么？

    1

    展开1条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2190202, encodeId=d60a2190202e6, content=这个期刊审稿时间大概多久呀，已经在in review阶段两周了，有没有好兄弟分享一下投稿经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16609175050, createdName=ms1000001807995731, createdTime=Thu Feb 29 21:35:47 CST 2024, time=2024-02-29, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2145244, encodeId=3c4c2145244ac, content=为什么影响因子降这么厉害？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50898365723, createdName=ms6000001780389235, createdTime=Wed Jun 28 17:40:58 CST 2023, time=2023-06-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=884750, encodeId=62df884e5085, content=被中国医院假论文承包，已经玩完, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9e32216429, createdName=pendrin_89355954, createdTime=Sat Sep 12 13:24:17 CST 2020, time=2020-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549342, encodeId=3a055493429d, content=文章接收后就发了一个电子版权说明的epub，也不是proof，该怎么办呢？什么时候交版面费呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=309, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7f662015, createdName=mh880926, createdTime=Mon Nov 20 13:39:00 CST 2017, time=2017-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806865, encodeId=c92e8068653d, content=已经发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72ed2455725, createdName=易小垂, createdTime=Sat Aug 08 00:06:11 CST 2020, time=2020-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096417, encodeId=13f5109641e8c, content=Graphicalabstract是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096418, encodeId=da34109641874, content=投稿中一定要有Graphicalabstract么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806864, encodeId=87ec80686407, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：乳腺癌逆转耐药 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72ed2455725, createdName=易小垂, createdTime=Sat Aug 08 00:05:45 CST 2020, time=2020-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893391, encodeId=a5668933917f, content=版面费多少？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a2285427691, createdName=ms7000000367412444, createdTime=Tue Oct 20 20:47:29 CST 2020, time=2020-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889945, encodeId=ba068899453d, content=已经被多家医院加入黑名单啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eaed2413645, createdName=1237fd56m52暂无昵称, createdTime=Sat Oct 03 20:00:14 CST 2020, time=2020-10-03, status=1, ipAttribution=)]
    2021-12-28 MS68862005

    投稿中一定要有Graphicalabstract么？

    1

    展开1条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2190202, encodeId=d60a2190202e6, content=这个期刊审稿时间大概多久呀，已经在in review阶段两周了，有没有好兄弟分享一下投稿经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16609175050, createdName=ms1000001807995731, createdTime=Thu Feb 29 21:35:47 CST 2024, time=2024-02-29, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2145244, encodeId=3c4c2145244ac, content=为什么影响因子降这么厉害？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50898365723, createdName=ms6000001780389235, createdTime=Wed Jun 28 17:40:58 CST 2023, time=2023-06-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=884750, encodeId=62df884e5085, content=被中国医院假论文承包，已经玩完, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9e32216429, createdName=pendrin_89355954, createdTime=Sat Sep 12 13:24:17 CST 2020, time=2020-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549342, encodeId=3a055493429d, content=文章接收后就发了一个电子版权说明的epub，也不是proof，该怎么办呢？什么时候交版面费呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=309, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7f662015, createdName=mh880926, createdTime=Mon Nov 20 13:39:00 CST 2017, time=2017-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806865, encodeId=c92e8068653d, content=已经发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72ed2455725, createdName=易小垂, createdTime=Sat Aug 08 00:06:11 CST 2020, time=2020-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096417, encodeId=13f5109641e8c, content=Graphicalabstract是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096418, encodeId=da34109641874, content=投稿中一定要有Graphicalabstract么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806864, encodeId=87ec80686407, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：乳腺癌逆转耐药 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72ed2455725, createdName=易小垂, createdTime=Sat Aug 08 00:05:45 CST 2020, time=2020-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893391, encodeId=a5668933917f, content=版面费多少？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a2285427691, createdName=ms7000000367412444, createdTime=Tue Oct 20 20:47:29 CST 2020, time=2020-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889945, encodeId=ba068899453d, content=已经被多家医院加入黑名单啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eaed2413645, createdName=1237fd56m52暂无昵称, createdTime=Sat Oct 03 20:00:14 CST 2020, time=2020-10-03, status=1, ipAttribution=)]
    2020-08-08 易小垂

    审稿速度:2.0 | 投稿命中率:50.0
    经验分享：乳腺癌逆转耐药

    1

    展开1条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2190202, encodeId=d60a2190202e6, content=这个期刊审稿时间大概多久呀，已经在in review阶段两周了，有没有好兄弟分享一下投稿经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16609175050, createdName=ms1000001807995731, createdTime=Thu Feb 29 21:35:47 CST 2024, time=2024-02-29, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2145244, encodeId=3c4c2145244ac, content=为什么影响因子降这么厉害？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50898365723, createdName=ms6000001780389235, createdTime=Wed Jun 28 17:40:58 CST 2023, time=2023-06-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=884750, encodeId=62df884e5085, content=被中国医院假论文承包，已经玩完, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9e32216429, createdName=pendrin_89355954, createdTime=Sat Sep 12 13:24:17 CST 2020, time=2020-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549342, encodeId=3a055493429d, content=文章接收后就发了一个电子版权说明的epub，也不是proof，该怎么办呢？什么时候交版面费呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=309, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7f662015, createdName=mh880926, createdTime=Mon Nov 20 13:39:00 CST 2017, time=2017-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806865, encodeId=c92e8068653d, content=已经发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72ed2455725, createdName=易小垂, createdTime=Sat Aug 08 00:06:11 CST 2020, time=2020-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096417, encodeId=13f5109641e8c, content=Graphicalabstract是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096418, encodeId=da34109641874, content=投稿中一定要有Graphicalabstract么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806864, encodeId=87ec80686407, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：乳腺癌逆转耐药 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72ed2455725, createdName=易小垂, createdTime=Sat Aug 08 00:05:45 CST 2020, time=2020-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893391, encodeId=a5668933917f, content=版面费多少？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a2285427691, createdName=ms7000000367412444, createdTime=Tue Oct 20 20:47:29 CST 2020, time=2020-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889945, encodeId=ba068899453d, content=已经被多家医院加入黑名单啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eaed2413645, createdName=1237fd56m52暂无昵称, createdTime=Sat Oct 03 20:00:14 CST 2020, time=2020-10-03, status=1, ipAttribution=)]
    2020-10-20 ms7000000367412444

    版面费多少？

    1

    展开1条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2190202, encodeId=d60a2190202e6, content=这个期刊审稿时间大概多久呀，已经在in review阶段两周了，有没有好兄弟分享一下投稿经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16609175050, createdName=ms1000001807995731, createdTime=Thu Feb 29 21:35:47 CST 2024, time=2024-02-29, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2145244, encodeId=3c4c2145244ac, content=为什么影响因子降这么厉害？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50898365723, createdName=ms6000001780389235, createdTime=Wed Jun 28 17:40:58 CST 2023, time=2023-06-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=884750, encodeId=62df884e5085, content=被中国医院假论文承包，已经玩完, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9e32216429, createdName=pendrin_89355954, createdTime=Sat Sep 12 13:24:17 CST 2020, time=2020-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549342, encodeId=3a055493429d, content=文章接收后就发了一个电子版权说明的epub，也不是proof，该怎么办呢？什么时候交版面费呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=309, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7f662015, createdName=mh880926, createdTime=Mon Nov 20 13:39:00 CST 2017, time=2017-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806865, encodeId=c92e8068653d, content=已经发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72ed2455725, createdName=易小垂, createdTime=Sat Aug 08 00:06:11 CST 2020, time=2020-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096417, encodeId=13f5109641e8c, content=Graphicalabstract是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096418, encodeId=da34109641874, content=投稿中一定要有Graphicalabstract么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806864, encodeId=87ec80686407, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：乳腺癌逆转耐药 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72ed2455725, createdName=易小垂, createdTime=Sat Aug 08 00:05:45 CST 2020, time=2020-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893391, encodeId=a5668933917f, content=版面费多少？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a2285427691, createdName=ms7000000367412444, createdTime=Tue Oct 20 20:47:29 CST 2020, time=2020-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889945, encodeId=ba068899453d, content=已经被多家医院加入黑名单啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eaed2413645, createdName=1237fd56m52暂无昵称, createdTime=Sat Oct 03 20:00:14 CST 2020, time=2020-10-03, status=1, ipAttribution=)]
    2020-10-03 1237fd56m52暂无昵称

    已经被多家医院加入黑名单啦

    0

共89条页码: 1/9页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分